Analysis laboratory to astm F1609-23 standard

Résolution de problème
More than 120 people
More than 120 people at your service
5200 m² laboratory
5200 m² laboratory + 99% of services are provided in-house
Accredited laboratory
Accredited laboratory COFRAC ISO 17025

You would like to analyze the hydroxylapatite content of your DM according to ASTM F1609-23

What does ASTM F1609-23 say ?

ASTM F1609-23 is a technical specification that details the requirements for calcium phosphate coatings used in surgical implant applications. Specifically, it covers their composition, application methods, and physical and mechanical characteristics. It covers both particulate and monolithic forms of calcium phosphate materials. The types of coating included in this specification are hydroxylapatite, tricalcium phosphate, and their combinations, with the possibility of minor additions of other ceramics or metals.

What are the analysis techniques described in ASTM F1609-23 ?

To ensure compliance, materials must undergo rigorous testing, including :

The FILAB laboratory can assist you with your analysis needs in accordance with ASTM F1609-23 standards.

Importance of ASTM F1609-23

ASTM F1609-23 is a fundamental pillar of the hydroxyapatite medical device industry. It guarantees that these materials comply with the most stringent quality requirements. It thus promotes the safety and efficacy of medical devices, and improves patients’ lives.

ASTM F1609-23

To find out more about these standards and how they apply to your industry, please contact us. We’re here to guide you towards high-quality, standards-compliant solutions for your medical devices.

Why perform analysis to ASTM F1609-23 standards ?

ASTM F1609-23 standards are crucial to the medical device industry for several reasons :

Quality Assurance : This guarantees that the beta-tricalcium phosphate materials used in medical devices comply with strict quality standards.
Patient Safety: By complying with these standards, medical devices are more likely to be safe to use and minimise risks to patients.
Clinical Effectiveness : ASTM F1609-23 standards contribute to the clinical effectiveness of medical devices, guaranteeing their reliability and performance.
Ease of comparison : This standard enables medical device manufacturers and regulators to compare and assess products in a consistent way.
Continuous Innovation : This encourages innovation by providing guidelines for the development of new medical devices based on hydroxyapatite and beta-tricalcium phosphate.

FILAB offers you a wide range of services, some of which are COFRAC 17025 accredited, to help you assess your medical devices

The FILAB laboratory has developed a wide range of skills in chemical analysis and materials characterisation to provide you with a comprehensive service for the chemical characterisation of all your biomaterials:

With our 3 levels of services – analysis, expertise and R&D support – our laboratory supports industrial companies of all sizes and in all sectors in solving their industrial problems. FILAB puts the know-how and expertise of its team at your disposal and provides you with a dedicated technical contact.

The filab advantages
A highly qualified team
A highly qualified team
Responsiveness in responding to and processing requests
Responsiveness in responding to and processing requests
A COFRAC ISO 17025 accredited laboratory
A COFRAC ISO 17025 accredited laboratory
(Staves available on www.cofrac.com - Accreditation number: 1-1793)
A complete analytical park of 5,200m²
A complete analytical park of 5,200m²
Tailor-made support
Tailor-made support
Thomas ROUSSEAU Scientific and Technical Director
Ask for your quote